Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1526 clinical trials
featured
[ONLINE] SPEECH BIOMARKERS: NEUROCOGNITIVE FUNCTIONING IN HEALTHY ADULTS

. Today, diagnosing neurodegenerative disorders like Alzheimer's Disease or Frontotemporal Degeneration depends on someone scoring below a low threshold on clinically-administered tests, which often means

  • 766 views
  • 22 Oct, 2020
  • 252 locations
featured
Autoimmune Features of Neurodegenerative Disorders

This study is looking for people over the age of 55 who have Alzheimer’s. The study is also looking for people who do not have Alzheimer’s, as a comparison. The study is interested in the relationship between cognition, health history, and immune factors.

dementia
mild cognitive impairment
cognitive impairment
  • 0 views
  • 05 Mar, 2021
  • 1 location
featured
Understanding the Microbiome-gut-brain axis in Alzheimer disease and its Role in Cognitive Decline

The purpose of the study is looking at imbalances of the gut microbiome and how it relates to progression of neurodegenerative disorders like Alzheimer's and Dementia.

  • 0 views
  • 29 Apr, 2021
  • 1 location
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

The purpose of this study is to evaluate the long-term safety and tolerability of pimavanserin in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease

  • 180 views
  • 17 Sep, 2021
  • 135 locations
A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

The purpose of this study is to assess the safety and tolerability of pimavanserin compared to placebo in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative

  • 120 views
  • 17 Sep, 2021
  • 126 locations
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

Alzheimer's disease (AD) and Parkinson's disease (PD) are currently the leading neurodegenerative disorders. Considering the fact that aged population is rapidly growing, it has become a

  • 0 views
  • 05 Aug, 2021
  • 1 location
Copaxone in Age Related Macular Degeneration

safe and effective agent for a neurodegenerative disease, in arresting the progression as well as the conversion of dry AMD to wet AMD. The hypothesis that the immunomodulatory agent copaxone

blindness
age-related macular degeneration
  • 45 views
  • 07 Nov, 2020
  • 1 location
Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy

(PSP), a neurodegenerative disorder with severe neuronal loss in the prefrontal cortex and cholinergic systems, in particular in the Meynert basalis nucleus. This could participate in the

cholinergic systems
neurodegenerative disorders
donepezil
  • 247 views
  • 07 Nov, 2020
  • 1 location
Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL

disorders, Obstructive disorders (e.g. nasal polyposis, tumors), posttraumatic (head trauma) and neurodegenerative disorders. Only a few studies have shown benefits of specific therapy for olfactory loss

  • 0 views
  • 24 Jan, 2021
  • 2 locations
Transcranial Magnetic Stimulation in Nonfluent/Agrammatic Variant Primary Progressive Aphasia

Nonfluent/agrammatic variant primary progressive aphasia (nf/avPPA) is a fatal neurodegenerative disease that begins with isolated language deficits. There is currently no cure or treatment for

  • 0 views
  • 29 Jan, 2021
  • 1 location